HIV / AIDS in the News

[CROI 2026] aidsmap: Oropharyngeal cancer is becoming more common in heterosexual men with HIV - European AIDS Treatment Group

 

Analysis of 9vHPV Vaccination Benefits in Men With HIV - Docwire News

 

Bictegravir/Lenacapavir Combo Pill Could Replace Complex HIV Treatment - poz.com

 

Oral Cancer Is Rising Among People With HIV - poz.com

 

Can GSK’s ViiV Healthcare Deliver Twice-Yearly HIV Therapy? - Healthcare Digital

 

CNBC Changemakers and Power Players Podcast: Gilead Sciences Chief Commercial & Corporate Affairs Officer and 2026 CNBC Changemaker Johanna Mercier on ending HIV epidemic, life hacks, and her leadership superpower - CNBC

 

Gilead, Merck Clear Path to Market for Daily HIV Pills With New Late-Stage Data - BioSpace

 

CROI 2026 highlights depression and cognitive vulnerability in HIV - bioworld.com

 

In a city with high HIV rates, one free clinic struggles to survive - WHRO

 

Kenya rolls out twice-yearly HIV prevention shot in Nairobi slum - africanews.com

 

A single daily pill against HIV to replace more complex treatments in patients with resistance - El Mundo America

 

PECO profits soar; HIV resources in one spot; Funeral cost assistance | Morning Roundup - Billy Penn at WHYY

 

Kenya becomes first in East Africa to launch six-month HIV prevention injection - WHO | Regional Office for Africa

 

South Africa: A year after USAID cuts - Al Jazeera

 

ViiV’s four-monthly HIV drug maintains viral suppression at 12 months - Clinical Trials Arena

 

Gilead data show investigational HIV combination maintains viral suppression - PharmaTimes

 

The 2026 Ruby Gala Makes Intersectional HIV Treatment Possible - Nfocus

 

HIV Stigma is Pervasive and Increasing Among US Adults - Williams Institute

 

Women and HIV: Get the Facts on HIV Testing, Prevention, and Treatment - fda.gov

 

Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy - BioSpace

 

New documentary ‘Ending HIV: The Journey to a Vaccine’ premieres at Boston’s Museum of Science - The Tufts Daily

 

Columbia expands free HIV testing to rural central Missouri - KOMU 8

 

Cuts to AIDS medication program set for Sunday; thousands of Floridians to lose access - wtsp.com

 

Thousands of Floridians living with HIV could soon lose access to life-saving medication - wtsp.com

 

Peoria resident shares HIV story amid high Black infection rates - CIProud.com

 

Review and mapping of Global Fund investments in priority comorbidities in Grand Cycle 7 to improve the health and well-being of people living with or at risk of HIV and/or TB (February 2026) - ReliefWeb

 

Hiv rises in Black Americans, funding for Black groups lags - CIProud.com

 

CAB+RPV LA Is Versatile, Preferred in Treatment-Naive Patients - AJMC

 

New single pill regimen simplifies treatment for resistant HIV - News-Medical

 

Columbia expands free HIV testing to rural central Missouri - KOMU 8